rhIL-15: Clinical Trials

1 trial of rhIL-15, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow rhIL-15: new trials by email Literature Review of rhIL-15 trials Research Report on rhIL-15

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma
rhIL-15, Avelumab - Clear-Cell Renal Carcinoma
Phase 2TerminatedNational Cancer Institute (NCI)22020-05-262022-05-17

Conditions studied

Carcinoma, Renal Cell (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

United States (1)

Top investigators

Kevin C Conlon, M.D. (1)

Results publications

PMID 32508818